封面
市場調查報告書
商品編碼
1708612

生物模擬市場:按產品/服務、應用、分銷管道和地區分類

Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年全球生物模擬市場規模將達到 27.77 億美元,到 2032 年將達到 86.899 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 17.7%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 27.77億美元
效能數據 2020-2024 預測期 2025-2032
預測期間:2025年至2032年的複合年成長率 17.70% 2032年價值預測 86.899億美元
數字。 2025年生物模擬市場佔有率(按地區)
生物模擬市場-IMG1

生物模擬是一種計算模型,使用電腦模擬來模擬人體內的生物過程、系統和途徑。它幫助我們了解人體在分子和細胞層面上如何運作,以及某些醫療干預措施(如藥物和醫療設備)如何發揮作用。透過從分子到組織層級等多個尺度模擬疾病機制、進展和與治療性介入的相互作用,生物模擬可以幫助減少藥物開發過程中對大量實驗室和臨床測試的需求。這降低了成本,提高了效率並加快了藥物研發。

市場動態

全球生物模擬市場的成長受到多種因素的推動,例如製藥和生物技術行業研發支出的增加、對降低藥物開發成本和開發時間的日益重視、個性化醫療的採用率的提高、慢性病患病率的增加以及生物模擬領域技術的快速進步。然而,由於缺乏處理複雜生物模擬工具和模型所需的合格IT基礎設施和熟練的專業人員,市場成長可能會受到抑制。該市場的關鍵機會來自於生物模擬應用領域的不斷擴大,例如疫苗開發、飲食和毒性分析、組織工程和個人化醫療,以及產業界和學術界之間為進一步推進該技術而進行的持續合作。

近年來,全球生物模擬市場經歷了重大技術進步,帶來了新的機會和應用。生物模擬是利用電腦建模和模擬來研究和預測生物過程。這使得研究人員能夠模擬細胞、組織和整個生物體等生物系統,以便更好地了解疾病並測試新的治療方法。

研究的主要特點

  • 本報告對全球生物模擬市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR%)。
  • 它還強調了各個領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球生物模擬市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球生物模擬市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過全球生物模擬市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章 全球生物模擬市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球生物模擬市場(依產品和服務分類),2020 年至 2032 年

  • 介紹
  • 軟體
  • 服務

6. 全球生物模擬市場(依應用分類),2020 年至 2032 年

  • 介紹
  • 藥物研發
  • 藥物開發

7. 2020-2032 年全球生物模擬市場(按分銷管道)

  • 介紹
  • 醫院藥房
  • 零售藥局
  • 網路藥局

8. 2020-2032 年全球生物模擬市場(按地區)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭態勢

  • Certara, LP
  • Simulations Plus, Inc.
  • Dassault Systemes(Accelrys)
  • Genedata AG
  • LeadScope, Inc.
  • Compugen Inc.
  • Schrodinger, LLC
  • In Silico Biosciences, Inc.
  • Advanced Chemistry Development, Inc.
  • Chemical Computing Group ULC
  • Physiomics PLC
  • Pharmaceutical Product Development, LLC(Evidera)

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI2016

Global Biosimulation Market is estimated to be valued at USD 2,777. Mn in 2025 and is expected to reach USD 8,689.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 17.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2,777. Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 17.70% 2032 Value Projection: USD 8,689.9 Mn
Figure. Biosimulation Market Share (%), By Region 2025
Biosimulation Market - IMG1

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics:

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study:

  • This report provides in-depth analysis of the global biosimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Biosimulation Market Detailed Segmentation:

  • By Product and Services
    • Software
    • Services
  • By Application
    • Drug Discovery
    • Drug Development
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Certara, L.P.
    • Simulations Plus, Inc.
    • Dassault Systemes (Accelrys)
    • Genedata AG
    • LeadScope, Inc.
    • Compugen Inc.
    • Schrodinger, LLC
    • In Silico Biosciences, Inc.
    • Advanced Chemistry Development, Inc.
    • Chemical Computing Group ULC
    • Physiomics PLC
    • Pharmaceutical Product Development, LLC (Evidera)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biosimulation Market Snippet, By Product and Services
    • Global Biosimulation Market Snippet, By Application
    • Global Biosimulation Market Snippet, By Distribution Channel
    • Global Biosimulation Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biosimulation Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biosimulation Market, By Product and Services, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Biosimulation Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Biosimulation Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Biosimulation Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Certara, L.P.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Simulations Plus, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dassault Systemes (Accelrys)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genedata AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LeadScope, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Compugen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schrodinger, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • In Silico Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced Chemistry Development, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Chemical Computing Group ULC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Physiomics PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pharmaceutical Product Development, LLC (Evidera)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us